Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 10,420Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Sanofi

02 1Algorithm

03 3Amneal Pharmaceuticals

04 3Aurobindo Pharma Limited

05 1Cooper Pharma Limited

06 1Eurofarma Laboratorios S.A

07 2Hanlim Pharmaceuticals Inc

08 3Hetero Drugs

09 1Kolmar Korea Co., Ltd.

10 3Kowa India

11 6Kowa Pharmaceuticals America

12 6Lupin Ltd

13 6Mepha Pharma

14 2Neopharma

15 3Orient Pharma

16 6Recordati

17 12Sandoz B2B

18 3Sawai Pharmaceutical Co., Ltd.

19 6Spirig Healthcare

20 3Tecnimede

21 3Viatris

22 2Wanbang Biopharmaceuticals

23 1Zim Laboratories

24 3Zydus Pharmaceuticals

25 9Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Switzerland

Pitavastatinum

Brand Name : Pitavastatin Zentiva

Dosage Form : Filmtabl

Dosage Strength : 1mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Sanofi Company Banner

02

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Switzerland

Pitavastatinum

Brand Name : Pitavastatin Zentiva

Dosage Form : Filmtabl

Dosage Strength : 1mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Sanofi Company Banner

03

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Switzerland

Pitavastatinum

Brand Name : Pitavastatin Zentiva

Dosage Form : Filmtabl

Dosage Strength : 2mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Sanofi Company Banner

04

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Switzerland

Pitavastatinum

Brand Name : Pitavastatin Zentiva

Dosage Form : Filmtabl

Dosage Strength : 2mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Sanofi Company Banner

05

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Switzerland

Pitavastatinum

Brand Name : Pitavastatin Zentiva

Dosage Form : Filmtabl

Dosage Strength : 4mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Sanofi Company Banner

06

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Switzerland

Pitavastatinum

Brand Name : Pitavastatin Zentiva

Dosage Form : Filmtabl

Dosage Strength : 4mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Sanofi Company Banner

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PITAVASTATIN CALCIUM

Brand Name : PITAVASTATIN CALCIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 1MG BASE

Packaging :

Approval Date : 2024-08-20

Application Number : 205961

Regulatory Info : RX

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PITAVASTATIN CALCIUM

Brand Name : PITAVASTATIN CALCIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2MG BASE

Packaging :

Approval Date : 2024-08-20

Application Number : 205961

Regulatory Info : RX

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PITAVASTATIN CALCIUM

Brand Name : PITAVASTATIN CALCIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 4MG BASE

Packaging :

Approval Date : 2024-08-20

Application Number : 205961

Regulatory Info : RX

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PITAVASTATIN CALCIUM

Brand Name : PITAVASTATIN CALCIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 1MG BASE

Packaging :

Approval Date : 2024-04-30

Application Number : 205977

Regulatory Info : RX

Registration Country : USA

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PITAVASTATIN CALCIUM

Brand Name : PITAVASTATIN CALCIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2MG BASE

Packaging :

Approval Date : 2024-04-30

Application Number : 205977

Regulatory Info : RX

Registration Country : USA

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PITAVASTATIN CALCIUM

Brand Name : LIVALO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 1MG BASE

Packaging :

Approval Date : 2009-08-03

Application Number : 22363

Regulatory Info : RX

Registration Country : USA

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PITAVASTATIN CALCIUM

Brand Name : LIVALO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2MG BASE

Packaging :

Approval Date : 2009-08-03

Application Number : 22363

Regulatory Info : RX

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PITAVASTATIN CALCIUM

Brand Name : LIVALO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 4MG BASE

Packaging :

Approval Date : 2009-08-03

Application Number : 22363

Regulatory Info : RX

Registration Country : USA

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PITAVASTATIN CALCIUM

Brand Name : PITAVASTATIN CALCIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 1MG BASE

Packaging :

Approval Date : 2017-02-03

Application Number : 205932

Regulatory Info : RX

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PITAVASTATIN CALCIUM

Brand Name : PITAVASTATIN CALCIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2MG BASE

Packaging :

Approval Date : 2017-02-03

Application Number : 205932

Regulatory Info : RX

Registration Country : USA

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PITAVASTATIN CALCIUM

Brand Name : PITAVASTATIN CALCIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 4MG BASE

Packaging :

Approval Date : 2017-02-03

Application Number : 205932

Regulatory Info : RX

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PITAVASTATIN CALCIUM

Brand Name : PITAVASTATIN CALCIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 1MG BASE

Packaging :

Approval Date : 2017-02-03

Application Number : 205955

Regulatory Info : RX

Registration Country : USA

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PITAVASTATIN CALCIUM

Brand Name : PITAVASTATIN CALCIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2MG BASE

Packaging :

Approval Date : 2017-02-03

Application Number : 205955

Regulatory Info : RX

Registration Country : USA

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PITAVASTATIN CALCIUM

Brand Name : PITAVASTATIN CALCIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 4MG BASE

Packaging :

Approval Date : 2017-02-03

Application Number : 205955

Regulatory Info : RX

Registration Country : USA

blank